TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198. (linkinghub.elsevier.com)

Authors: Trachtman H … Soleymanlou N Journal: The Lancet Published: 2026-02-07 DOI: https://doi.org/10.1016/S0140-6736(25)02255-X